Icagen Licenses Dotmatics Software | GenomeWeb

NEW YORK (GenomeWeb News) – Biopharmaceutical company Icagen has licensed Dotmatics' Browser query and visualization platform for data handling and project management, the UK-based software maker said today.

Specifically, Icagen will use the platform to query, browse, analyze, and share drug research data across its programs and teams.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.